Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage

Recruiting now · Not applicable

Conditions studied: Intracerebral Hemorrhage, Nontraumatic Intracerebral Hemorrhage

In brief

This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.

Key facts

Study ID

NCT05504941

Run by

University Hospital, Basel, Switzerland

People needed

15

Starts

2022-10-25

Expected to finish

2026-12-01

Last updated by the study team

2025-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of an acute spontaneous ICH based on non-contrast CT
• Time from symptom onset to anticipated start of cerebral DSA of under 3 hours
• Agreement of the treating physician to perform DSA
• Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent)

You may not qualify if…

• High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the treating physician
• Any time critical surgical or minimal invasive intervention is planned
• Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential
• Contraindications against the use of iodine contrast media
• Known severe kidney insufficiency (Glomerular filtration rate < 30 ml/min)

Where it is running

• Department of Neuroradiology, University Hospital Basel — Basel, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.